Cargando…

UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study

Rheumatoid arthritis (RA) is characterized by systemic inflammation and synovial hyperplasia. Pristimerin, a natural triterpenoid isolated from plants belonging to the Celastraceae and Hippocrateaceae families, has been reported to exhibit anti-inflammation and anti-proliferation activities. Our stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Mengying, Liang, Qiaoling, Luo, Zhaoyong, Han, Bo, Ni, Tengyang, Wang, Yang, Tao, Li, Lyu, Weiting, Xiang, Jie, Liu, Yanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505172/
https://www.ncbi.nlm.nih.gov/pubmed/36144243
http://dx.doi.org/10.3390/metabo12090839
_version_ 1784796406184148992
author Lv, Mengying
Liang, Qiaoling
Luo, Zhaoyong
Han, Bo
Ni, Tengyang
Wang, Yang
Tao, Li
Lyu, Weiting
Xiang, Jie
Liu, Yanqing
author_facet Lv, Mengying
Liang, Qiaoling
Luo, Zhaoyong
Han, Bo
Ni, Tengyang
Wang, Yang
Tao, Li
Lyu, Weiting
Xiang, Jie
Liu, Yanqing
author_sort Lv, Mengying
collection PubMed
description Rheumatoid arthritis (RA) is characterized by systemic inflammation and synovial hyperplasia. Pristimerin, a natural triterpenoid isolated from plants belonging to the Celastraceae and Hippocrateaceae families, has been reported to exhibit anti-inflammation and anti-proliferation activities. Our study aims to reveal the antiarthritic effects of pristimerin and explore its potential mechanism using in vitro, in silico, and in vivo methods. In the present study, pristimerin treatment led to a dose-dependent decrease in cell viability and migration in TNF-α stimulated human rheumatoid arthritis fibroblast-like synoviocytes MH7A. Moreover, UPLC-LTQ-Orbitrap-based cell metabolomics analysis demonstrated that phospholipid biosynthesis, fatty acid biosynthesis, glutathione metabolism and amino acid metabolic pathways were involved in TNF-α induced MH7A cells after pristimerin treatment. In addition, the adjuvant–induced arthritis (AIA) rat model was employed, and the results exhibited that pristimerin could effectively relieve arthritis symptoms and histopathological damage as well as reduce serum levels of TNF-α, NO and synovial expressions of p-Akt and p-Erk in AIA rats. Furthermore, network pharmacology analysis was performed to visualize crucial protein targets of pristimerin for RA treatment, which showed that the effects were mediated through the MAPK/Erk1/2, PI3K/Akt pathways and directing binding with TNF-α. Taken together, our study not only offered new insights into the biochemical mechanism of natural compounds for RA treatment, but also provided a strategy that integrated in vitro, in silico and in vivo studies to facilitate screening of new anti-RA drugs.
format Online
Article
Text
id pubmed-9505172
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95051722022-09-24 UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study Lv, Mengying Liang, Qiaoling Luo, Zhaoyong Han, Bo Ni, Tengyang Wang, Yang Tao, Li Lyu, Weiting Xiang, Jie Liu, Yanqing Metabolites Article Rheumatoid arthritis (RA) is characterized by systemic inflammation and synovial hyperplasia. Pristimerin, a natural triterpenoid isolated from plants belonging to the Celastraceae and Hippocrateaceae families, has been reported to exhibit anti-inflammation and anti-proliferation activities. Our study aims to reveal the antiarthritic effects of pristimerin and explore its potential mechanism using in vitro, in silico, and in vivo methods. In the present study, pristimerin treatment led to a dose-dependent decrease in cell viability and migration in TNF-α stimulated human rheumatoid arthritis fibroblast-like synoviocytes MH7A. Moreover, UPLC-LTQ-Orbitrap-based cell metabolomics analysis demonstrated that phospholipid biosynthesis, fatty acid biosynthesis, glutathione metabolism and amino acid metabolic pathways were involved in TNF-α induced MH7A cells after pristimerin treatment. In addition, the adjuvant–induced arthritis (AIA) rat model was employed, and the results exhibited that pristimerin could effectively relieve arthritis symptoms and histopathological damage as well as reduce serum levels of TNF-α, NO and synovial expressions of p-Akt and p-Erk in AIA rats. Furthermore, network pharmacology analysis was performed to visualize crucial protein targets of pristimerin for RA treatment, which showed that the effects were mediated through the MAPK/Erk1/2, PI3K/Akt pathways and directing binding with TNF-α. Taken together, our study not only offered new insights into the biochemical mechanism of natural compounds for RA treatment, but also provided a strategy that integrated in vitro, in silico and in vivo studies to facilitate screening of new anti-RA drugs. MDPI 2022-09-05 /pmc/articles/PMC9505172/ /pubmed/36144243 http://dx.doi.org/10.3390/metabo12090839 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lv, Mengying
Liang, Qiaoling
Luo, Zhaoyong
Han, Bo
Ni, Tengyang
Wang, Yang
Tao, Li
Lyu, Weiting
Xiang, Jie
Liu, Yanqing
UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study
title UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study
title_full UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study
title_fullStr UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study
title_full_unstemmed UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study
title_short UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study
title_sort uplc-ltq-orbitrap-based cell metabolomics and network pharmacology analysis to reveal the potential antiarthritic effects of pristimerin: in vitro, in silico and in vivo study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505172/
https://www.ncbi.nlm.nih.gov/pubmed/36144243
http://dx.doi.org/10.3390/metabo12090839
work_keys_str_mv AT lvmengying uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT liangqiaoling uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT luozhaoyong uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT hanbo uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT nitengyang uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT wangyang uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT taoli uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT lyuweiting uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT xiangjie uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy
AT liuyanqing uplcltqorbitrapbasedcellmetabolomicsandnetworkpharmacologyanalysistorevealthepotentialantiarthriticeffectsofpristimerininvitroinsilicoandinvivostudy